Welcome to LookChem.com Sign In|Join Free

CAS

  • or

756520-70-4

Post Buying Request

756520-70-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

756520-70-4 Usage

Description

4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine is a complex organic compound that features a morpholine ring and a boron atom. It has a molecular formula of C16H27BO3N and a molecular weight of 291.2 g/mol. This versatile chemical is known for its potential applications across various industries due to its unique structure and properties.

Uses

Used in Pharmaceutical and Agrochemical Development:
4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine is used as a building block in organic synthesis for the development of new pharmaceuticals and agrochemicals. Its unique structure allows it to be a key component in the creation of novel compounds with potential therapeutic and agricultural benefits.
Used in Polymer and Material Manufacturing:
In the manufacturing industry, 4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine is utilized in the production of polymers and materials. Its incorporation into these products can enhance their properties, such as stability, durability, and performance.
Used in Organic Electronics and Optoelectronics:
4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine is also used in the field of organic electronics and optoelectronics. Its interesting electronic properties make it a promising candidate for applications in devices such as solar cells, light-emitting diodes, and transistors, where its unique characteristics can contribute to improved performance and efficiency.
Overall, 4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine is a versatile chemical with a wide range of potential uses in various industries, including pharmaceuticals, materials science, and electronics. Its unique structure and properties make it a valuable asset in the development of innovative products and technologies.

Check Digit Verification of cas no

The CAS Registry Mumber 756520-70-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,6,5,2 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 756520-70:
(8*7)+(7*5)+(6*6)+(5*5)+(4*2)+(3*0)+(2*7)+(1*0)=174
174 % 10 = 4
So 756520-70-4 is a valid CAS Registry Number.

756520-70-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]morpholine

1.2 Other means of identification

Product number -
Other names B-4653

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:756520-70-4 SDS

756520-70-4Relevant articles and documents

MACROCYCLIC COMPOUNDS AND USES THEREOF

-

, (2021/08/27)

Described herein are macrocyclic compounds of Formula (I), which can inhibit kinases such as EGFR, including mutant forms such as T790M EGFR mutants. Also described herein are pharmaceutical compositions comprising a compound of Formula (I), or any pharmaceutically acceptable form thereof, processes for their preparation, and use in therapy for the prevention or treatment of cancer. In particular, compounds described herein can be effective for treating EGFR-driven cancers including non-small cell lung cancer (NSCLC).

TREATMENT OF GVHD

-

, (2015/11/18)

The invention relates to treatment of graft versus host disease (GVHD) using compounds that inhibit ROCK2. In preferred aspects, the present invention provides methods for the treatment of GVHD, including chronic GVHD ( cGVHD) using compounds having the formulae l-XXV, as set forth herein.

Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors

-

, (2008/06/13)

The present invention relates to 8-amino-aryl-substituted imidazopyrazines which modulate the activity of protein kinases (“PKs”). The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 756520-70-4